https://www.selleckchem.com/pr....oducts/nvp-bgt226.ht
We found a statistically significant decrease in the severity of motor and nonmotor symptoms in the study group in the posttransplant period. Positive results allow us to consider MSCs transplantation as a disease-modifying therapeutic strategy in PD. However, this method of PD treatment is not a fully understood process, which requires additional studies and a longer follow-up period to monitor the patients' condition posttransplantation. Positive results allow us to consider MSCs transplantation as a disease-modifying therapeutic s
Like
Comment
Share
